Liu Qing-Feng, Hao Peng, Wang Tao
Department of Urology, Langzhong People's Hospital, Nanchong, Sichuan Province, China.
Department of Urology, Dazhou Dachuan District People's Hospital, (Dazhou Third People's Hospital), Beijing, Sichuan Province, China.
J Robot Surg. 2025 May 24;19(1):232. doi: 10.1007/s11701-025-02379-1.
This analysis aims to compare the outcomes of robotic cystectomy in patients with bladder cancer who are under 80 years of age versus those who are 80 years or older.
A thorough search was conducted across key databases, including Google Scholar, Cochrane Library, PubMed, EMBASE, and Web of Science, with the most recent search conducted in July 2024. Data analysis was performed using Stata 18, applying a random-effects meta-analysis model. Weighted mean differences were calculated for continuous data, and odds ratios for categorical variables, accompanied by 95% confidence intervals.
Four studies were included in the meta-analysis. The baseline data revealed significant differences in age, sex distribution, BMI, ASA scores (≥ 3), and cT2 staging between the two age groups. Patients aged 80 and above had significantly longer surgical durations and a greater number of lymph nodes removed compared to those under 80. Marked heterogeneity was observed in the younger cohort, which showed higher rates of urinary diversion to the neobladder and pelvic lymph node dissection. Blood loss, hospitalization duration, total complications, minor complications, and major complications did not differ notably between the age groups.
This study suggests that robot-assisted radical cystectomy (RARC) is a viable and safe procedure for carefully selected elderly patients when performed in high-volume specialized centers. However, the small sample size, intermediate follow-up period, and potential for selection bias warrant caution in interpreting long-term outcomes. Future multi-center studies with longer follow-ups are needed to confirm these findings and establish standardized criteria for patient selection.
本分析旨在比较80岁以下与80岁及以上膀胱癌患者接受机器人膀胱切除术的结果。
对包括谷歌学术、考克兰图书馆、PubMed、EMBASE和科学网在内的主要数据库进行了全面检索,最近一次检索于2024年7月进行。使用Stata 18进行数据分析,应用随机效应荟萃分析模型。计算连续数据的加权平均差和分类变量的比值比,并伴有95%置信区间。
荟萃分析纳入了四项研究。基线数据显示,两个年龄组在年龄、性别分布、BMI、ASA评分(≥3)和cT2分期方面存在显著差异。80岁及以上患者的手术时间明显更长,切除的淋巴结数量更多,与80岁以下患者相比。在较年轻队列中观察到明显的异质性,该队列显示新膀胱尿流改道和盆腔淋巴结清扫的发生率更高。年龄组之间的失血量、住院时间、总并发症、轻微并发症和严重并发症没有显著差异。
本研究表明,机器人辅助根治性膀胱切除术(RARC)对于精心挑选的老年患者来说,在高容量的专业中心进行时是一种可行且安全的手术。然而,样本量小、随访期中等以及存在选择偏倚的可能性,在解释长期结果时需谨慎。需要未来进行更长随访期的多中心研究来证实这些发现并建立患者选择的标准化标准。